-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.50900% Upside
Invivyd, Inc. Frequently Asked Questions
-
What analysts cover Invivyd, Inc.?
Invivyd, Inc. has been rated by research analysts at Guggenheim, Morgan Stanley in the past 90 days.